Position in ZTS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,340,547
-$50,127,730 QoQ
Shares Held
18,655
-95.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#573
of 1,408 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 27%
Shared 73%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $152,241,305 across 13 Drug Manufacturers - Specialty & Generic names. ZTS ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COLL |
Collegium Pharmaceutical, Inc
|
1,405,567 | $50,881,525 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
629,836 | $29,772,346 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
431,324 | $27,583,169 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
102,414 | $17,260,854 | |
| 5 | HLN |
Haleon plc
|
957,121 | $8,929,938 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
475,589 | $6,891,283 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
144,366 | $5,923,336 | |
| 8 | ZTS |
Zoetis Inc.
This page
|
18,655 | $1,340,547 |
All Filings in ZTS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,340,547 | 18,655 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $51,468,277 | 435,397 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $55,243,029 | 439,064 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $45,728,070 | 312,521 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $28,262,816 | 181,230 | Shares | Sole | 2025-08-08 | |
| 2024-03-31 | $230,238,459 | 1,360,667 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $609,565,201 | 3,088,439 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $647,339,733 | 3,720,771 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $723,642,088 | 4,202,091 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $716,406,524 | 4,304,293 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $654,106,284 | 4,463,366 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $738,569,611 | 4,980,576 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $916,289,895 | 5,330,676 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $984,602,927 | 5,220,865 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,308,161,858 | 5,360,660 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,035,975,300 | 5,336,228 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,006,311,011 | 5,399,823 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $869,070,227 | 5,518,607 | Shares | Sole | 2021-05-13 | |
| 2020-09-30 | $1,040,173,659 | 6,289,978 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $859,432,928 | 6,271,402 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $791,339,790 | 6,723,934 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||